2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Carcinoma, Renal Cell
70
Carcinoma, Hepatocellular
25
Prostatic Neoplasms
21
Neoplasm Metastasis
19
Neoplasms
17
Carcinoma, Non-Small-Cell Lung
16
Kidney Neoplasms
14
Osteosarcoma
9
Neuroendocrine Tumors
9
Carcinoma, Transitional Cell
9
Carcinoma, Medullary
9
Sarcoma
8
Colorectal Neoplasms
8
Urinary Bladder Neoplasms
7
Sarcoma, Ewing
7
Melanoma
7
Breast Neoplasms
7
Brain Neoplasms
7
Thyroid Neoplasms
6
Ovarian Neoplasms
6
Clear-cell metastatic renal cell carcinoma
6
Recurrence
5
Pancreatic Neoplasms
5
Lung Neoplasms
5
Carcinoma
5
Urethral Neoplasms
4
Triple Negative Breast Neoplasms
4
Multiple Myeloma
4
Liver Neoplasms
4
Thyroid Cancer, Papillary
3
Interventions
Fentanyl
27
Analgesia
23
Morphine
20
Acupuncture Therapy
18
Surveys and Questionnaires
16
Oxycodone
16
Zoledronic Acid
15
Acetaminophen
14
Therapeutics
13
Radiotherapy
13
Psychiatric Rehabilitation
13
Ketamine
13
Methadone
11
Lidocaine
11
Hydromorphone
11
Bupivacaine
11
nabiximols
10
Ibandronic Acid
10
Ropivacaine
9
Early Intervention, Educational
7
Analgesics, Opioid
7
Saline Solution
6
Music Therapy
6
Cryotherapy
6
Cryosurgery
6
Yoga
5
Water
5
Tapentadol
5
Pregabalin
5
Methods
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Pain
×
cabozantinib
×
Clear all
NCT01522443
2018-05-23
COMET-2
Exelixis
Phase 3
Terminated
119 enrolled
21 charts
NCT01605227
2018-03-14
COMET-1
Exelixis
Phase 3
Completed
1,028 enrolled
18 charts